PHARMACEUTICALS

Exclusive: More Indian buyers may line up for the remaining bits of Teva’s assets

October 17, 2016 | Ranjani Raghavan

Some more Indian pharma firms may end up buying the remaining bits of Teva Pharmaceuticals’ products across the European Economic Area (EEA) region, two people familiar with the transaction told VCCircle.

Exclusive: PE firm IVFA clocks decent returns from first partial exit this year

October 12, 2016 | Joseph Rai

Private equity firm India Value Fund Advisors (IVFA) has marked first partial exit from its portfolio firms this year marking an unusually quick churn, albeit partially, from a fairly young portfolio firm.

Consolidation has been slow in Indian healthcare: Cipla’s Chandru Chawla

October 10, 2016 | Ranjani Raghavan

Indian drugmaker Cipla revived its inorganic expansion strategy in 2013 and has been pursuing acquisitions at a frenetic pace since then. The firm has announced acquisition deals worth well over $1 billion in the past three years alone.

Piramal to buy five products from Janssen Pharmaceutica for up to $175 mn

October 10, 2016 | TEAM VCC

Ajay Piramal-led Piramal Enterprises Ltd has sealed a deal to buy a clutch of products from Janssen Pharmaceutica NV for up to $175 million, it said on Monday. It joins other Indian pharma companies like Lupin, Cipla and Intas that have inked big overseas deals abroad in the last one year.

Exclusive: Cipla eyes fresh push into China

October 06, 2016 | Ranjani Raghavan

Indian pharmaceuticals giant Cipla Ltd that has scaled down its business in China over the last three-four years even as it has been aggressively looking at overseas acquisitions is now relooking at its strategy.

Temasek-backed Intas to buy Teva’s operations under Actavis in UK & Ireland for $769 mn

October 05, 2016 | TEAM VCC

World’s largest generic drugmaker Teva Pharmaceutical Industries Ltd said on Wednesday it has agreed to sell assets and operations of Actavis Generics in the UK and Ireland to Intas Pharmaceuticals Ltd, for £603 million ($769 million or Rs 5,117 crore).

Exclusive: Bharat Serums & Vaccines raises fresh PE money

October 04, 2016 | Ranjani Raghavan

Bharat Serums & Vaccines Ltd. has raised additional capital as part of a larger transaction where the promoters sold some shares and existing private equity investor rolled over its investments into a separate fund, two persons familiar with the transaction told VCCircle.

Jacob Ballas makes modest returns from Vivimed Labs’ part-exit

October 03, 2016 | Ranjani Raghavan

Mid-market private equity firm Jacob Ballas Capital has marked its third liquidity event this year as it looks to harvest its investments from its last India-focused funds raised almost a decade ago.

Vitalic Health, Athena Life tie up to launch nutraceutical products

September 28, 2016 | Joseph Rai

Chennai-based Vitalic Health Pvt. Ltd said on Wednesday it has stitched a deal with Athena Life Sciences Pvt. Ltd to float nutraceuticals and dietary supplements maker Vitalic Nutrition.

Exclusive: Cipla BioTec hires banker for biggest PE fundraise in biosimilar space

September 23, 2016 | Ranjani Raghavan

Cipla BioTec Pvt Ltd, the bio-similar firm incubated by pharmaceuticals giant Cipla Ltd to develop anti-cancer drugs, has initiated the process for a large private equity funding, a top company executive told VCCircle.

Pages

Advertisement

Upcoming Events